A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

NCT06517758 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Myasthenia Gravis

Interventions

DRUG: Iptacopan
OTHER: Matching Placebo

Sponsor

Novartis Pharmaceuticals